The epigenetic inactivation of secretogranin V (SCG5/SGNE1/7B2) was a frequent early event in glioma formation, resulting in significant downregulation of SCG5/SGNE1/7B2 expression [67]. The gene discussed is SCG5; the disease is central nervous system cancer.